U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270211) titled 'MCG In Long QT Syndrome' on Nov. 25.
Brief Summary: The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Atrial Fibrillation
Intervention:
DIAGNOSTIC_TEST: Magnetocardiography
MCG is a non-invasive, radiation-free imaging tec...